These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 12673842

  • 1. Prevention of red cell dehydration: a possible new treatment for sickle cell disease.
    Mueller BU, Brugnara C.
    Pediatr Pathol Mol Med; 2001; 20(1):15-25. PubMed ID: 12673842
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Oral magnesium supplements reduce erythrocyte dehydration in patients with sickle cell disease.
    De Franceschi L, Bachir D, Galacteros F, Tchernia G, Cynober T, Alper S, Platt O, Beuzard Y, Brugnara C.
    J Clin Invest; 1997 Oct 01; 100(7):1847-52. PubMed ID: 9312186
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. In vitro inhibitory effects of disodium cromoglycate on ionic transports involved in sickle cell dehydration.
    Bizumukama L, Ferster A, Gulbis B, Kumps A, Cotton F.
    Pharmacology; 2009 Oct 01; 83(5):318-22. PubMed ID: 19401631
    [Abstract] [Full Text] [Related]

  • 11. Treatment with oral clotrimazole blocks Ca(2+)-activated K+ transport and reverses erythrocyte dehydration in transgenic SAD mice. A model for therapy of sickle cell disease.
    De Franceschi L, Saadane N, Trudel M, Alper SL, Brugnara C, Beuzard Y.
    J Clin Invest; 1994 Apr 01; 93(4):1670-6. PubMed ID: 7512989
    [Abstract] [Full Text] [Related]

  • 12. The treatment of sickle cell anemia with induced hyponatremia.
    Rosa RM, Bierer BE, Bunn HF, Epstein FH.
    Blood Cells; 1982 Apr 01; 8(2):329-35. PubMed ID: 7159756
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Abnormal permeability pathways in human red blood cells.
    Ellory JC, Robinson HC, Browning JA, Stewart GW, Gehl KA, Gibson JS.
    Blood Cells Mol Dis; 2007 Apr 01; 39(1):1-6. PubMed ID: 17434766
    [Abstract] [Full Text] [Related]

  • 19. O2 dependence of K+ transport in sickle cells: the effect of different cell populations and the substituted benzaldehyde 12C79.
    Gibson JS, Khan A, Speake PF, Ellory JC.
    FASEB J; 2001 Mar 01; 15(3):823-32. PubMed ID: 11259401
    [Abstract] [Full Text] [Related]

  • 20. Mouse models of sickle cell disease.
    Beuzard Y.
    Transfus Clin Biol; 2008 Mar 01; 15(1-2):7-11. PubMed ID: 18502677
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.